Quick Answer
ClearPoint Neuro, Inc. reported Operating Income Loss of -$24.16 million for the year ending 2025.
- ClearPoint Neuro, Inc. showed a decrease of -22.4% in Operating Income Loss from 2024 to 2025.
- This data is from ClearPoint Neuro, Inc.'s annual report (Form 10-K), filed with the SEC on March 17, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2012: -$479.5 thousand | Q3 2012: -$1.02 million | Q1 2013: -$1.37 million | Q2 2013: -$2.18 million | Q3 2013: -$1.86 million | Q1 2014: $2.19 million | Q2 2014: -$2.22 million | Q3 2014: -$2.62 million | Q1 2015: -$2.94 million | Q2 2015: -$2.68 million | Q3 2015: -$1.93 million | Q1 2016: -$1.93 million | Q2 2016: -$2.06 million | Q3 2016: -$1.71 million | Q1 2017: -$1.35 million | Q2 2017: -$1.82 million | Q3 2017: -$1.33 million | Q1 2018: -$1.43 million | Q2 2018: -$1.64 million | Q3 2018: -$1.21 million | Q1 2019: -$972.2 thousand | Q2 2019: -$1.29 million | Q3 2019: -$910.5 thousand | Q1 2020: -$1.21 million | Q2 2020: -$1.48 million | Q3 2020: -$1.27 million | Q1 2021: -$2.18 million | Q2 2021: -$3.41 million | Q3 2021: -$3.80 million | Q1 2022: -$3.86 million | Q2 2022: -$4.20 million | Q3 2022: -$3.80 million | Q1 2023: -$5.71 million | Q2 2023: -$7.13 million | Q3 2023: -$4.90 million | Q1 2024: -$4.22 million | Q2 2024: -$4.72 million | Q3 2024: -$5.16 million | Q1 2025: -$6.16 million | Q2 2025: -$5.68 million | Q3 2025: -$5.28 million.
- Over the full 16 years of available data (2010 to 2025), ClearPoint Neuro, Inc.'s Operating Income Loss has declined by 153.9%.
- Historical annual values: Fiscal year 2025: -$24.16 million | Fiscal year 2024: -$19.73 million | Fiscal year 2023: -$22.45 million | Fiscal year 2022: -$16.33 million | Fiscal year 2021: -$13.37 million | Fiscal year 2020: -$6.22 million | Fiscal year 2019: -$4.59 million | Fiscal year 2018: -$5.25 million | Fiscal year 2017: -$6.34 million | Fiscal year 2016: -$7.49 million | Fiscal year 2015: -$8.97 million | Fiscal year 2014: -$5.32 million | Fiscal year 2013: -$7.47 million | Fiscal year 2012: -$3.13 million | Fiscal year 2011: -$5.92 million | Fiscal year 2010: -$9.52 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: